Old Republic International (ORI) Q4 2025 earnings summary

Executive summary

• Consolidated pre-tax operating income for Q4 was $236 million, down from $285 million, with a combined ratio of 96% versus 92.7% last year; full-year pre-tax operating income reached $1 billion and a combined ratio of 94.7%.

• Q4 2025 operating EPS was $0.74, a 17.8% decrease year-over-year, mainly due to a 21.8% drop in Specialty Insurance pretax operating income, partially offset by an 18.1% increase in Title Insurance.

• Book value per share increased 22% to $24.21, including dividends, reflecting strong earnings and investment valuations.

• Net premiums and fees earned rose 9.8% to $2.13 billion, driven by growth in both Specialty (up 8.3%) and Title Insurance (up 12.4%).

• Total capital returned to shareholders was $742 million for the quarter, including dividends and share repurchases.

Financial highlights

• Total operating revenues for 2025 were $8.96 billion, up from $8.16 billion in 2024.

• Net operating income for Q4 was $185 million, down from $227 million; EPS was $0.74 versus $0.90 year-over-year.

• Net investment income increased 7.9% in Q4, driven by higher bond yields and a larger investment base; bond portfolio book yield rose to 4.75%.

• Combined ratio for Q4 was 96%, up from 92.7% last year, and 94.7% for the full year, up from 93.9%.

• Cash dividends declared per share increased 23.2% for the quarter and 19.6% for the year.

Outlook and guidance

• Specialty insurance combined ratio target for 2026 is expected to be consistent with 2025's 93.2%, with a focus on pricing and underwriting discipline.

• Title business expects commercial premiums to improve 15-20% in 2026, with residential premiums rising 3-7%.

• Net investment income growth is expected to slow in 2026 due to the current interest rate environment.

• Management targets combined ratios between 90% and 95% over a full underwriting cycle for both Specialty and Title Insurance segments.

• Acquisition of Everett Cash Mutual (ECM) announced, expected to be accretive to book value per share and operating EPS, pending regulatory approval in 2026.